IQVIA与SCRI合作简化全球癌症临床试验IQVIA and SCRI Partner to Streamline Global Cancer Clinical Trials

动脉网2025-05-17

IQVIA has entered into a strategic partnership with SCRI Development Innovations.IQVIA与SCRI Development Innovations建立了战略合作伙伴关系。The collaboration aims to improve the way oncology trials are conducted ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2536308242?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-17 14:21","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2536308242","market":"us","top_or_hot":-1,"title":"IQVIA与SCRI合作简化全球癌症临床试验IQVIA and SCRI Partner to Streamline Global Cancer Clinical Trials","media":"动脉网","content":"<div>\n<p>IQVIA has entered into a strategic partnership with SCRI Development Innovations.IQVIA与SCRI Development Innovations建立了战略合作伙伴关系。The collaboration aims to improve the way oncology trials are conducted ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051714220794f9afa1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IQVIA与SCRI合作简化全球癌症临床试验IQVIA and SCRI Partner to Streamline Global Cancer Clinical Trials</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIQVIA与SCRI合作简化全球癌症临床试验IQVIA and SCRI Partner to Streamline Global Cancer Clinical Trials\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-17 14:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051714220794f9afa1&s=b><strong>动脉网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>IQVIA has entered into a strategic partnership with SCRI Development Innovations.IQVIA与SCRI Development Innovations建立了战略合作伙伴关系。The collaboration aims to improve the way oncology trials are conducted ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051714220794f9afa1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1201861249.SGD","symbol_name":"Natixis Harris Associates US Equity PA SGD-H","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051714220794f9afa1&s=b","article_id":"2536308242","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051714220794f9afa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2536308242","pubTimestamp":1747462860,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"IQVIA has entered into a strategic partnership with SCRI Development Innovations.IQVIA与SCRI Development Innovations建立了战略合作伙伴关系。By bringing together IQVIA’s extensive global network and data integration capabilities with SCRI’s community oncology expertise, the partnership is expected to streamline trial operations. The collaboration will support faster trial activation, improved patient recruitment, and quicker access to trial data..通过将IQVIA广泛的全球网络和数据集成能力与SCRI的社区肿瘤学专业知识相结合，该合作伙伴关系预计将简化试验操作。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1201861249.SGD":"Natixis Harris Associates US Equity PA SGD-H","LU0648000940.SGD":"Natixis Harris Associates Global Equity RA SGD","LU0130102774.USD":"Natixis Harris Associates US Equity RA USD","LU0130517989.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"R\" INC","LU0882574055.USD":"富达全球健康医疗A ACC","LU0980610538.SGD":"Natixis Harris Associates US Equity RA SGD-H","BK4585":"ETF&股票定投概念","IQV":"艾昆纬","LU0648001328.SGD":"Natixis Harris Associates US Equity RA SGD","LU1261432733.SGD":"Fidelity World A-ACC-SGD","LU0477156797.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"RE\" (USD) ACC","LU0130518102.USD":"HARRIS ASSOCIATES GLOBAL EQUITY \"R\" INC","BK4530":"医药外包概念","LU0477156953.USD":"HARRIS ASSOCIATES US VALUE EQUITY \"RE\" (USD) ACC","BK4588":"碎股","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU0528227936.USD":"富达环球人口趋势基金A-ACC","LU0198837287.USD":"UBS (LUX) EQUITY SICAV - USA GROWTH \"P\" (USD) ACC","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU0130103400.USD":"Natixis Harris Associates Global Equity RA USD","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU1201861165.SGD":"Natixis Harris Associates Global Equity PA SGD","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","BK4121":"生命科学工具和服务"},"translate_title":"IQVIA partners with SCRI to streamline global cancer clinical trials IQVIA and SCRI Partner to Streamline Global Cancer Clinical Trials","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IQV":0.9},"content_text":"IQVIA has entered into a strategic partnership with SCRI Development Innovations.IQVIA与SCRI Development Innovations建立了战略合作伙伴关系。The collaboration aims to improve the way oncology trials are conducted worldwide, benefiting biopharmaceutical companies and ultimately patients.该合作旨在改善全球范围内肿瘤学试验的开展方式，使生物制药公司乃至最终患者受益。By bringing together IQVIA’s extensive global network and data integration capabilities with SCRI’s community oncology expertise, the partnership is expected to streamline trial operations. The collaboration will support faster trial activation, improved patient recruitment, and quicker access to trial data..通过将IQVIA广泛的全球网络和数据集成能力与SCRI的社区肿瘤学专业知识相结合，该合作伙伴关系预计将简化试验操作。此次合作将支持更快的试验启动、改善患者招募，并加速获取试验数据。Central to this effort is SCRI’s Accelero operational model, which simplifies trial delivery at its U.S. research sites. Accelero links electronic health records with trial data systems, making the clinical trial process more efficient. IQVIA contributes its experience in managing a significant share of oncology trials in the United States, along with its strength in combining data, technology, and analytics..这项工作的核心是SCRI的Accelero操作模型，该模型简化了其美国研究站点的试验交付。Accelero将电子健康记录与试验数据系统连接起来，使临床试验过程更加高效。IQVIA贡献了其在美国管理很大一部分肿瘤试验的经验，以及其在数据、技术和分析结合方面的能力。Together, the organisations aim to remove common barriers in clinical trials and help accelerate the development of innovative cancer treatments.这些组织共同致力于消除临床试验中的常见障碍，帮助加速创新癌症治疗方法的开发。The joint approach is expected to offer a more effective and unified solution for trial sponsors, supporting the delivery of new therapies to patients at a faster pace.联合方法有望为试验赞助方提供更有效且统一的解决方案，支持更快地将新疗法交付给患者。Source: iqvia.com来源：iqvia.com","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2536308242","isCrawlerRequest":true}